Skip to the page

Data / Form D filings / MCAL Therapeutics Inc.

MCAL Therapeutics Inc.: Form D filings

MCAL Therapeutics Inc., a company in Park City, UT, filed 2 Form D notices with the SEC between 2020 and 2024. The latest, on March 27, 2024, reports $5.9 million sold of a $5.9 million offering to 29 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
291 Daly Ave, Park City, UT, 84060
Phone
(510) 914-1896
Industry
Other
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2020
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1812100

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Mar 27, 2024New notice$5,887,549$5,887,54929Mar 12, 2024sec.gov
Jun 4, 2020New notice$449,994$449,9945May 20, 2020sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Tom GadekExecutive Officer, Director
Charles O'NeillDirector
Chris J. MurphyDirector
Dan J. AlbertDirector
Tom J. MatherDirector

Other companies in Utah that filed recently

Every Form D from the week of Mar 25, 2024 · All recent filings in Utah · All recent Other filings

Read from SEC EDGAR. Amount sold is what MCAL Therapeutics Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.